Ixabepilone and SBRT For Metastatic Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: METASTATIC BREAST CANCER
Interventions: DRUG: IXABEPILONE|RADIATION: STEREOTACTIC BODY RADIATION THERAPY
Sponsor: University of Texas Southwestern Medical Center